Pitch & Connect
Discover innovative startups and connect with key players in the Basel Area ecosystem
🚀 Get ready for our first Pitch & Connect of the year at the Main Campus and join us for an inspiring session where you’ll discover resident startups and community members of our Novartis and Main Campus site.
Atlas Bio is an early-stage company that predicts clinical effects better with AI than animal models do. By modeling patient-specific, heterogeneous therapeutic responses, we enable predictive simulations that drive rational trial design, improve translatability, and minimize the need for in vivo experimentation.
Insilico Medicine is a global clinical-stage end-to-end AI-driven biotech. Its end-to-end Pharma.AI platform across Biology, Chemistry & Clinical Development along with its Automated Robotic Lab, accelerates Target Discovery & Validation, Small Molecule, Peptide, Nanobody and Antibody Generation, Design and Optimization, setting new R&D productivity benchmarks, and a growing pipeline of development candidates across disease areas.
Scailyte is an AI enabled company transforming precision medicine for the medical R&D community. Discovering novel and accurate biomarkers of disease from single cell data which reduces the time taken and the risks in drug development.
🌟 What to expect:
🔥 Short & impactful pitches from promising startups
🤝 Networking opportunity with passionate individuals over a sandwich lunch following the pitches
Participation is free. However, registration is required before 5th May 2025.
Program
11:15
Door opening and registration
11:30
Welcome
- Lauren Dickel, Community and Operations Manager, Switzerland Innovation Park Basel Area
11:35
Atlas Bio pitch and Q&A
- Simon Romanski, CEO, Atlas Bio
11:55
Insilico Medicine pitch and Q&A
- Ricardo Gaminha Pacheco, MD, MBA, MPH, Insilico Medicine
12:15
Scailyte pitch and Q&A
- Peter Nestorov, Co-Founder & CEO, Scailyte,
12:35
Lunch & networking
